Biolidics Balance Sheet Health

Financial Health criteria checks 2/6

Biolidics has a total shareholder equity of SGD-2.8M and total debt of SGD886.0K, which brings its debt-to-equity ratio to -31.6%. Its total assets and total liabilities are SGD504.0K and SGD3.3M respectively.

Key information

-31.6%

Debt to equity ratio

S$886.00k

Debt

Interest coverage ration/a
CashS$166.00k
Equity-S$2.81m
Total liabilitiesS$3.31m
Total assetsS$504.00k

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 8YY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: 8YY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: 8YY has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: 8YY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 8YY has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: 8YY is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies